Continuous- and semicontinuous-flow blood centrifugation systems: therapeutic applications, with plasma-, platelet, lympha-, and eosinapheresis
- PMID: 143740
- DOI: 10.1046/j.1537-2995.1977.17578014576.x
Continuous- and semicontinuous-flow blood centrifugation systems: therapeutic applications, with plasma-, platelet, lympha-, and eosinapheresis
Abstract
Blood centrifugation, with a continuous-flow or semicontinuous-flow system, was used in the treatment of 17 patients with various hematologic disorders. Total plasma exchange (TPE) controlled symptoms of hyperviscosity and arrested bleeding in three patients. In two patients, TPE made is possible to perform urgent surgical procedures. It was a very valuable adjuvant in the treatment of one patient with a Factor VIII inhibitor. Eosinapheresis was not of significant value in the therapy of syndromes associated with eosinophilia. Lymphapheresis significantly reduced peripheral lymphocytosis, aiding in the chemotherapeutic control of chronic lymphosarcoma cell leukemia in one patient. It was of questionable value in the maintenance therapy of two patients with Sézary syndrome. Plateletapheresis significantly reduced peripheral platelet count in thrombocytosis, making it possible to minimize the chemotherapeutic dose and permitting urgent surgical procedures in two patients.
Similar articles
-
[Application of plasmapheresis in patients with malignant paraproteinemia and hyperviscosity syndrome].Zhonghua Yi Xue Za Zhi (Taipei). 1988 Nov;42(5):367-72. Zhonghua Yi Xue Za Zhi (Taipei). 1988. PMID: 3255475 Chinese. No abstract available.
-
Plasma exchange in the management of hyperviscosity syndromes.Bibl Haematol. 1981;(47):228-41. doi: 10.1159/000402229. Bibl Haematol. 1981. PMID: 7337664 No abstract available.
-
[Hemodilution and plasmapheresis in the therapy of hyperviscosity syndromes].Ric Clin Lab. 1983;13 Suppl 3:225-44. Ric Clin Lab. 1983. PMID: 6424221 Italian.
-
Correction of hyperviscosity by apheresis.Semin Thromb Hemost. 2003 Oct;29(5):535-42. doi: 10.1055/s-2003-44560. Semin Thromb Hemost. 2003. PMID: 14631553 Review.
-
[Blood hyperviscosity syndromes. Classification and physiopathological understanding. Therapeutic deductions].Ann Med Interne (Paris). 1983;134(5):395-410. Ann Med Interne (Paris). 1983. PMID: 6360007 Review. French.
Cited by
-
Purification of human eosinophil-derived neurotoxin.Proc Natl Acad Sci U S A. 1981 Aug;78(8):5165-9. doi: 10.1073/pnas.78.8.5165. Proc Natl Acad Sci U S A. 1981. PMID: 6946462 Free PMC article.
-
Plasma lipid and apoprotein levels following plasmapheresis in a subject homozygous for familial hypercholesterolemia.Experientia. 1981 Feb 15;37(2):114-5. doi: 10.1007/BF01963177. Experientia. 1981. PMID: 7238731 No abstract available.
-
Localization of eosinophil granule major basic protein in human basophils.J Exp Med. 1983 Sep 1;158(3):946-61. doi: 10.1084/jem.158.3.946. J Exp Med. 1983. PMID: 6350526 Free PMC article.
-
Role of therapeutic apheresis and phlebotomy techniques in anaesthesia and critical care.Indian J Anaesth. 2014 Sep;58(5):672-8. doi: 10.4103/0019-5049.144685. Indian J Anaesth. 2014. PMID: 25535434 Free PMC article. Review.
-
Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. Evidence of a functional role for ProMBP.J Clin Invest. 1991 Sep;88(3):798-805. doi: 10.1172/JCI115379. J Clin Invest. 1991. PMID: 1715886 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources